Evidence map›Paper›PMID 23319086›Full record

ReviewCurrent gastroenterology reports2013

Role of liver biopsy in the era of direct-acting antivirals.

Humberto C Gonzalez, Syed Mohammed Jafri, Stuart C Gordon

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current gastroenterology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. A comparative study of cirrhosis sub-staging using the Laennec system, Beijing classification, and morphometry.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Humberto C GonzalezHenry Ford Health System, 2799 W. Grand Boulevard, Detroit, MI, 48202, USA.
Syed Mohammed Jafri
Stuart C Gordon

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An accurate assessment of the degree of fibrosis or presence of cirrhosis is critical both for the appropriate management of, and to provide prognosis for, patients with chronic hepatitis C infection. In the new era of direct acting antivirals, large numbers of patients may enter therapy, and although liver biopsy remains the gold standard, it is not practical in all settings. In recent years, a variety of noninvasive methods have been developed that may obviate the need for liver biopsy in most settings. Indirect laboratory formulas, tests, panels of biomarkers and imaging modalities may accurately stage the degree of fibrosis in hepatitis C monoinfection, hepatitis C/HIV coinfection, and post-transplant recurrent hepatitis C.

Indexed as

Elasticity Imaging TechniquesSeverity of Illness IndexAntiviral AgentsBiomarkersBiopsyHepatitis C, ChronicHumansLiverLiver CirrhosisMagnetic Resonance ImagingAntiviral AgentsBiomarkers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.